Total Payments
$741,599
2024 Payments
$30,790
Companies
23
Transactions
1,116
Medicare Patients
91
Medicare Billing
$13,149
Payment Breakdown by Category
Other$606,221 (81.7%)
Travel$92,566 (12.5%)
Food & Beverage$25,568 (3.4%)
Consulting$17,233 (2.3%)
Education$10.73 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $534,246 | 243 | 72.0% |
| Travel and Lodging | $92,566 | 404 | 12.5% |
| Honoraria | $71,975 | 34 | 9.7% |
| Food and Beverage | $25,568 | 423 | 3.4% |
| Consulting Fee | $17,233 | 10 | 2.3% |
| Education | $10.73 | 1 | 0.0% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$741,599
1,115 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $363,778 | 473 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, LLC | $178,865 | 269 | $0 (2020) |
| BioXcel Therapeutics, Inc. | $69,306 | 141 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $68,923 | 103 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $14,335 | 29 | $0 (2022) |
| Allergan Inc. | $13,584 | 31 | $0 (2018) |
| AcelRx Pharmaceuticals, Inc. | $10,337 | 17 | $0 (2021) |
| The Medicines Company | $9,381 | 17 | $0 (2017) |
| Melinta Therapeutics, Inc. | $9,178 | 10 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,363 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,790 | 35 | Janssen Pharmaceuticals, Inc ($12,300) |
| 2023 | $110,182 | 199 | BioXcel Therapeutics, Inc. ($62,363) |
| 2022 | $119,905 | 161 | Janssen Pharmaceuticals, Inc ($84,151) |
| 2021 | $30,989 | 47 | Janssen Pharmaceuticals, Inc ($18,820) |
| 2020 | $33,453 | 45 | PORTOLA PHARMACEUTICALS, LLC ($19,522) |
| 2019 | $103,555 | 167 | PORTOLA PHARMACEUTICALS, INC. ($54,953) |
| 2018 | $187,867 | 275 | PORTOLA PHARMACEUTICALS, INC. ($104,390) |
| 2017 | $124,859 | 187 | Janssen Pharmaceuticals, Inc ($100,615) |
All Payment Transactions
1,116 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Rare Disease | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $665.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $36.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: Rare Disease | ||||||
| 06/13/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $114.10 | General |
| Category: Rare Disease | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $19.30 | General |
| Category: Rare Disease | ||||||
| 05/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $94.82 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $15.48 | General |
| Category: Rare Disease | ||||||
| 02/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,641.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $942.68 | General |
| Category: Rare Disease | ||||||
| 02/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $16.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $36.18 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $109.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $227.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $21.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $120.26 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,040.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 27 | $35,538 | $3,292 |
| 2022 | 1 | 13 | 14 | $21,466 | $2,104 |
| 2021 | 1 | 22 | 22 | $32,273 | $3,427 |
| 2020 | 1 | 29 | 29 | $40,252 | $4,327 |
Total Patients
91
Total Services
92
Medicare Billing
$13,149
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 13 | 13 | $20,488 | $1,894 | 9.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 14 | 14 | $15,050 | $1,397 | 9.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 13 | 14 | $21,466 | $2,104 | 9.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 22 | 22 | $32,273 | $3,427 | 10.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 29 | 29 | $40,252 | $4,327 | 10.7% |
About Dr. Robert Takla, MD
Dr. Robert Takla, MD is a Emergency Medicine healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700831385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Takla, MD has received a total of $741,599 in payments from pharmaceutical and medical device companies, with $30,790 received in 2024. These payments were reported across 1,116 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($534,246).
As a Medicare-enrolled provider, Takla has provided services to 91 Medicare beneficiaries, totaling 92 services with total Medicare billing of $13,149. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Southfield, MI
- Active Since 05/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1700831385
Products in Payments
- XARELTO (Drug) $363,885
- ANDEXXA (Biological) $139,185
- ANDEXXA (Drug) $72,574
- IGALMI (Drug) $69,306
- BEVYXXA (Drug) $31,815
- DALVANCE (Drug) $13,573
- Andexxa (Drug) $12,028
- DSUVIA (Drug) $10,337
- Orbactiv (Drug) $9,178
- BRILINTA (Drug) $5,589
- ORBACTIV (Drug) $5,287
- MINOCIN IV (Drug) $4,094
- PRADAXA (Drug) $1,300
- CD cobas Reagents (Device) $971.01
- LOKELMA (Drug) $859.86
- MD cobas Instruments and Reagents (Device) $368.40
- Kcentra (Biological) $144.47
- ENTRESTO (Drug) $140.24
- Descovy (Drug) $120.05
- EkoSonic (Device) $93.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Southfield
Dr. Gary Pilchak, D.o, D.O
Emergency Medicine — Payments: $13,547
Emergency Medicine $13,547
Abdulrazak Alchakaki, M.d, M.D
Emergency Medicine — Payments: $6,328
Emergency Medicine $6,328
Peter Donaldson, Md, MD
Emergency Medicine — Payments: $4,809
Emergency Medicine $4,809
Margarita Pena, Md, MD
Emergency Medicine — Payments: $2,619
Emergency Medicine $2,619
Dr. Cynane Robinson, D.o, D.O
Emergency Medicine — Payments: $1,848
Emergency Medicine $1,848
Dr. Nicholas Dyc, M.d, M.D
Emergency Medicine — Payments: $806.83
Emergency Medicine $806.83